Popular New
- AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL15 daysExperimental Hematology & OncologyRead
- Targeting phosphoglycerate dehydrogenase in multiple myeloma17 daysExperimental Hematology & OncologyRead
- The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers17 daysExperimental Hematology & OncologyRead
- Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML17 daysExperimental Hematology & OncologyRead
- Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country36 daysExperimental Hematology & OncologyRead
- CD44 as a tumor biomarker and therapeutic target45 daysExperimental Hematology & OncologyRead
- Applications of gut microbiota in patients with hematopoietic stem-cell transplantation50 daysExperimental Hematology & OncologyRead
- Engineering better chimeric antigen receptor T cells51 daysExperimental Hematology & OncologyRead
- Recent updates for antibody therapy for acute lymphoblastic leukemia56 daysExperimental Hematology & OncologyRead
- Complex roles of cAMP–PKA–CREB signaling in cancer59 daysExperimental Hematology & OncologyRead
- Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia70 daysExperimental Hematology & OncologyRead
- Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma70 daysExperimental Hematology & OncologyRead
- Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study81 daysExperimental Hematology & OncologyRead
- Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma93 daysExperimental Hematology & OncologyRead
- The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017116 daysExperimental Hematology & OncologyRead
- Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of thera119 daysExperimental Hematology & OncologyRead
- miR-100 inhibits cell proliferation in mantle cell lymphoma by targeting mTOR119 daysExperimental Hematology & OncologyRead
- Frontiers in the COVID-19 vaccines development142 daysExperimental Hematology & OncologyRead
- Regulation of metabolic reprogramming by tumor suppressor genes in pancreatic cancer142 daysExperimental Hematology & OncologyRead
- Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells142 daysExperimental Hematology & OncologyRead
- Risk factors and outcome of COVID-19 in patients with hematological malignancies151 daysExperimental Hematology & OncologyRead
- Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study165 daysExperimental Hematology & OncologyRead
- Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study170 daysExperimental Hematology & OncologyRead
- Pancreatic cancer resistance conferred by stellate cells: looking for new preclinical models172 daysExperimental Hematology & OncologyRead
- The frequency and inter-relationship of PD-L1 expression and tumour mutational burden across multiple types of advanced solid tumours in China172 daysExperimental Hematology & OncologyRead
- SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in COVID-19 patients190 daysExperimental Hematology & OncologyRead
- Macrophage, the potential key mediator in CAR-T related CRS197 daysExperimental Hematology & OncologyRead
- Medicine - All Feeds
- Allergology and Immunology
- Anatomy and Physiology
- Anesthesiology and Intensive Care
- Biochemistry
- Bioengineering
- Biophysics
- Biotechnology
- Cardiology
- Cardiothoracic Surgery
- Clinical Chemistry
- Clinical Medicine
- Complementary Medicine
- Cytology and Histology
- Dentistry
- Dermatology
- Endocrinology
- Forensic Medicine
- Gastroenterology
- General Practice
- Genetics
- Geriatrics
- Health services and Administration
- Hematology
- Infectious Diseases
- Internal Medicine
- Logopedics
- Medical Education and Humanities
- Medical Microbiology
- Medicine - Other
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Nutritional Sciences
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Oral and Maxillofacial Surgery
- Orthopedics and Traumatology
- Otorhinolaryngology and Phoniatrics
- Pathology
- Pediatrics
- Pharmacology and Pharmacotherapy
- Physical and Rehabilitation Medicine
- Plastic Surgery
- Psychiatry
- Psychology
- Public Health
- Radiology
- Respiratory Medicine
- Rheumatology
- Sports Medicine
- Surgery
- Urology